InvestorsHub Logo
Followers 110
Posts 5606
Boards Moderated 0
Alias Born 09/28/2011

Re: dr_lowenstein post# 177187

Monday, 01/04/2016 3:45:24 PM

Monday, January 04, 2016 3:45:24 PM

Post# of 413906
Building a strong consensus of physicians and pharmaceutical experts promotes the case for Elite to pursue ELI-200 and its proprietary technology as the choice for abuse deterrent drugs.

Cheers!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News